☆ 4.7 Editorial Material

Defining pelvic-radiation disease for the survivorship era

LANCET ONCOLOGY (2010)

期刊

LANCET ONCOLOGY

卷 11, 期 4, 页码 310-312

出版社

ELSEVIER SCIENCE INC

DOI: 10.1016/S1470-2045(10)70026-7

关键词

-

类别

Oncology

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Review Oncology

Defining disease modification in myelofibrosis in the era of targeted therapy

Naveen Pemmaraju, Srdan Verstovsek, Ruben Mesa, Vikas Gupta, Jacqueline S. Garcia, Joseph M. Scandura, Stephen T. Oh, Francesco Passamonti, Konstanze Dohner, Adam J. Mead

Summary: This article discusses the definition of disease modification in myelofibrosis and the recent clinical trials of developing therapeutic drugs, emphasizing the need for surrogate measures of survival in early-stage trials.

CANCER (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Defining the Failure of Medical Therapy for Inflammatory Bowel Disease in the Era of Advanced Therapies: A Systematic Review

Monica State, Lucian Negreanu

Summary: There is a lack of clear definitions and guidelines for the response criteria and treatment optimization in advanced therapies for inflammatory bowel disease, leading to inconsistent treatment strategies and premature abandonment of effective therapies.

BIOMEDICINES (2023)

添加到收藏夹

Article Orthopedics

Contemporary Porous Titanium Acetabular Components for Total Hip Arthroplasty After Pelvic Radiation

Elizabeth P. Wellings, Cory G. Couch, Michael J. Taunton, Mark W. Pagnano, Daniel J. Berry, Matthew P. Abdel

Summary: In patients with prior pelvic radiation, contemporary porous titanium acetabular components with supplemental screws provided excellent implant fixation, radiographic stability, and significant clinical improvement. At 10 years, all components were free of aseptic loosening revisions and demonstrated radiographic evidence of secure fixation.

JOURNAL OF ARTHROPLASTY (2021)

添加到收藏夹

Review Oncology

Female erectile tissues and sexual dysfunction after pelvic radiotherapy: A scoping review

Deborah C. Marshall, Elizabeth S. Tarras, Ayesha Ali, Julie Bloom, Mylin A. Torres, Jenna M. Kahn

Summary: This scoping review highlights the lack of scientific research on the impacts of radiotherapy on female erectile tissues and the difficulty in designing studies due to the lack of biomedical data. Collaborative interdisciplinary research is needed to generate radiobiologic and clinical evidence to improve sexual outcomes in female patients.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

添加到收藏夹

Review Oncology

A Systematic Review of Population-Based Studies of Chronic Bowel Symptoms in Cancer Survivors following Pelvic Radiotherapy

Adam Biran, Iakov Bolnykh, Ben Rimmer, Anthony Cunliffe, Lisa Durrant, John Hancock, Helen Ludlow, Ian Pedley, Colin Rees, Linda Sharp

Summary: Pelvic radiotherapy can cause chronic bowel symptoms, such as bleeding, pain, and incontinence, and understanding the prevalence and severity of these symptoms is important for providing support and treatment. A systematic review of population-based studies found a wide range of bowel symptoms following pelvic radiotherapy, with prevalence ranging from 1% to 59%. The review highlights the need for more research and consistent methods to better inform the provision of services and support.

CANCERS (2023)

添加到收藏夹

Review Biology

The effects of ionizing radiation on domestic dogs: a review of the atomic bomb testing era

Gabriella J. Spatola, Elaine A. Ostrander, Timothy A. Mousseau

Summary: The review looks at the use of dogs as laboratory subjects during the era of atomic bomb testing and summarizes the biological effects of exposure to radiation and radionuclides on a mid-sized mammal. It demonstrates the wide range of developmental and physiological effects that can result from such exposure.

BIOLOGICAL REVIEWS (2021)

添加到收藏夹

Article Medicine, General & Internal

Low-grade intestinal inflammation two decades after pelvic radiotherapy

Sravani Devarakonda, Annika Thorsell, Per Hedenstrom, Azar Rezapour, Lisen Heden, Sanghita Banerjee, Malin E. V. Johansson, George Birchenough, Amelie Toft Moren, Karin Gustavsson, Viktor Skokic, Victor L. Pettersson, Fei Sjoberg, Marie Kalm, Mohammad Al Masri, Michaela Ekh, Henrik Fagman, Mats Wolving, Rosie Perkins, Rodrigo A. Morales, Francisca Castillo, EduardoJ. Villablanca, Ulf Yrlid, Karin Bergmark, Gunnar Steineck, Cecilia Bull

Summary: Radiotherapy is effective in cancer treatment but can also harm non-cancerous tissue. This study examined the presence of chronic inflammation in mucosal biopsies from pelvic cancer survivors who received radiotherapy. The findings suggest the presence of a chronic low-grade inflammation with neutrophil activity, supporting the exploration of new strategies to alleviate chronic bowel symptoms in these survivors.

EBIOMEDICINE (2023)

添加到收藏夹

Article Oncology

Defining research and infrastructure priorities for cancer survivorship in Australia: a modified Delphi study

Fiona Crawford-Williams, Bogda Koczwara, Raymond J. Chan, Janette Vardy, Karolina Lisy, Julia Morris, Mahesh Iddawela, Gillian Mackay, Michael Jefford

Summary: The aim of this study was to establish research and infrastructure priorities for cancer survivorship. The study surveyed Australian experts in cancer survivorship to determine the priorities in various research categories and the type of research needed. The results can be used to support coordinated action between researchers, funding bodies, and other key stakeholders.

SUPPORTIVE CARE IN CANCER (2022)

添加到收藏夹

Review Hematology

Defining curative endpoints for transfusion-dependent β-thalassemia in the era of gene therapy and gene editing

Selim Corbacioglu, Haydar Frangoul, Franco Locatelli, William Hobbs, Mark Walters

Summary: Beta-thalassemia is a monogenic disease that causes anemia. Transfusion-dependent beta-thalassemia (TDT) is the most severe form, requiring lifelong transfusions. Current treatments address symptoms, but gene therapies may offer a one-time functional cure. Selecting endpoints for evaluation is a significant challenge.

AMERICAN JOURNAL OF HEMATOLOGY (2023)

添加到收藏夹

Article Oncology

Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021

H. J. Burstein, G. Curigliano, B. Thurlimann, W. P. Weber, P. Poortmans, M. M. Regan, H. J. Senn, E. P. Winer, M. Gnant

Summary: The 17th St Gallen International Breast Cancer Consensus Conference in 2021 was held virtually, with over 3300 participants discussing key issues related to early breast cancer diagnosis and treatment. The conference emphasized customized recommendations for breast cancer treatment, highlighting the importance of individualized clinical features in patient care.

ANNALS OF ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Cardiotoxicity screening of long-term, breast cancer survivors-The CAROLE (Cardiac-Related Oncologic Late Effects) Study

Lindsay L. Puckett, Shahryar G. Saba, Sonia Henry, Stacey Rosen, Elise Rooney, Samaria L. Filosa, Philip Gilbo, Karalyn Pappas, Alison Laxer, Katherine Eacobacci, Amitha N. Kapyur, Justin Robeny, Samantha Musial, Anisha Chaudhry, Rahul Chaudhry, Martin L. Lesser, Adam Riegel, Sariah Ramoutarpersaud, Navid Rahmani, Amar Shah, Vivian Papas, Toluwani Dawodu, Jessica Charlton, Jonathan P. S. Knisely, Lucille Lee

Summary: This study identified a high incidence of cardiovascular disease in heterogeneous long-term breast cancer survivors, with over half having clinical findings warranting follow-up and/or intervention. Each imaging test independently contributed to the detection rate, suggesting that long-term cardiac screening may be valuable for a wider group of breast cancer survivors than previously recognized.

CANCER MEDICINE (2021)

添加到收藏夹

Article Oncology

Radiation therapy for extensive-stage small-cell lung cancer in the era of immunotherapy

Yaru Tian, Ji Ma, Xuquan Jing, Xiaoyang Zhai, Yuying Li, Zhijun Guo, Jinming Yu, Hui Zhu

Summary: Unlike NSCLC, the progression of SCLC is slow. ES-SCLC poses a serious threat to human health with a low 5-year survival rate. Chemotherapy has been the first-line treatment, but anti-PD-L1 checkpoint blockades have emerged as standard therapy. The combination of radiation therapy and immunotherapy in ES-SCLC has limited evidence and requires further prospective trials.

CANCER LETTERS (2022)

添加到收藏夹

Article Environmental Sciences

The challenges of defining hormesis in epidemiological studies: The case of radiation hormesis

Ivo Iavicoli, Luca Fontana, Carolina Santocono, Davide Guarino, Martina Laudiero, Edward J. Calabrese

Summary: In the current radiation protection system, the linear no-threshold extrapolation model is used to determine preventive measures and occupational exposure limits for ionizing radiation. However, increasing evidence suggests that this model poorly predicts biological responses to low-dose exposure. Furthermore, studies have shown the presence of hormetic dose response curves correlated to low exposure to ionizing radiation. Rating: 7/10

SCIENCE OF THE TOTAL ENVIRONMENT (2023)

添加到收藏夹

Article Pediatrics

Defining kidney outcomes in children with acute lymphoblastic leukemia in the modern era

Reeti Kumar, Suzanne Reed, Joseph R. Stanek, John D. Mahan

Summary: This study investigated the incidence of acute kidney injury (AKI), chronic kidney disease (CKD), and hypertension (HTN) in pediatric patients diagnosed with acute lymphoblastic leukemia (ALL). The results showed a relatively high incidence of AKI at the time of diagnosis, a low incidence of CKD, and a high incidence of untreated chronic HTN.

PEDIATRIC NEPHROLOGY (2022)

添加到收藏夹

Review Oncology

Pelvic Extirpative Surgery for the End-Stage Irradiated Bladder

Nikolas Moring, Seamus Barrett, Andrew C. Peterson, Brian M. Inouye

Summary: Men with prostate cancer face the challenge of choosing from various treatment options. The long-term effects of radiation therapy are now being recognized. The end-stage irradiated bladder presents problems for patients and surgeons, particularly in managing urosymphyseal fistula, radiation cystitis, and rectourethral fistula. This review emphasizes the importance of considering cystectomy as a safe and feasible option for select irradiated patients to improve their quality of life.

CANCERS (2023)

添加到收藏夹

Article Oncology

Bowel dysfunction in survivors of gynaecologic malignancies

Yolanda Ribas, Marta Bonet, Laura Torres, Miriam Nunez, E. Esther Jovell-Fernandez, Eduard Aranda, H. Jervoise Andreyev

SUPPORTIVE CARE IN CANCER (2020)

添加到收藏夹

Review Oncology

Systematic review: the effect of right hemicolectomy for cancer on postoperative bowel function

C. Hope, J. Reilly, J. Lund, H. J. N. Andreyev

SUPPORTIVE CARE IN CANCER (2020)

添加到收藏夹

Article Oncology

The FOCCUS study: a prospective evaluation of the frequency, severity and treatable causes of gastrointestinal symptoms during and after chemotherapy

H. Jervoise N. Andreyev, Amyn Lalji, Kabir Mohammed, Ann C. G. Muls, David Watkins, Sheela Rao, Naureen Starling, Ian Chau, Sarah Cruse, Ville Pitkaaho, Jennifer Matthews, Laura Caley, Victoria Pittordou, Carolyn Adams, Linda Wedlake

Summary: Patients undergoing chemotherapy for gastrointestinal malignancy often experience challenging gastrointestinal symptoms that require active management, which is not routinely conducted. The underlying causes of these symptoms are often treatable or curable.

SUPPORTIVE CARE IN CANCER (2021)

添加到收藏夹

Article Oncology

Gastrointestinal Toxicity of Pelvic Radiotherapy: Are We Letting Women Down?

D. C. R. Fernandes, H. J. N. Andreyev

Summary: For women diagnosed with gynecological cancers, progress has been made in prevention, early diagnosis, and therapy, but living with and beyond has been largely ignored. Patients treated for gynecological cancer often face long-term issues that are not adequately addressed, particularly in terms of side-effects of cancer therapies, such as radiation. There is a need for better assessment and treatment of these side effects to improve quality of life for long-term survivors.

CLINICAL ONCOLOGY (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab

Nicholas A. Kennedy, James R. Goodhand, Claire Bewshea, Rachel Nice, Desmond Chee, Simeng Lin, Neil Chanchlani, Jeffrey Butterworth, Rachel Cooney, Nicholas M. Croft, Ailsa L. Hart, Peter M. Irving, Klaartje B. Kok, Christopher A. Lamb, Jimmy K. Limdi, Jonathan Macdonald, Dermot Pb McGovern, Shameer J. Mehta, Charles D. Murray, Kamal Patel, Richard C. G. Pollok, Timothy Raine, Richard K. Russell, Christian P. Selinger, Philip J. Smith, Jack Bowden, Timothy J. McDonald, Charlie W. Lees, Shaji Sebastian, Nicholas Powell, Tariq Ahmad

Summary: The study found that patients with inflammatory bowel disease treated with infliximab had attenuated serological responses to SARS-CoV-2 infection. Additionally, the serological response to SARS-CoV-2 infection in the infliximab-treated group was further blunted by concomitant use of immunomodulators.

GUT (2021)

添加到收藏夹

Article Oncology

Impact of Pelvic Radiation Therapy for Prostate Cancer on Global Metabolic Profiles and Microbiota-Driven Gastrointestinal Late Side Effects: A Longitudinal Observational Study

Miguel R. Ferreira, Caroline J. Sands, Jia Li, Jervoise N. Andreyev, Elena Chekmeneva, Sarah Gulliford, Julian Marchesi, Matthew R. Lewis, David P. Dearnaley

Summary: The study found that patients undergoing PLNRT treatment experienced significant changes in metabolites in urine, plasma, and stool, and these metabolites did not return to baseline levels within 1 year. The increase in molecules associated with cardiovascular risk in plasma and the association between pre-PLNRT fecal butyrate levels and gastrointestinal side effects suggest long-term metabolic effects that warrant further investigation.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Nivolumab-induced exocrine pancreatic insufficiency

Anna Jones, Kay Rodgers, Debbie Jeffrey, Waqas Ali, H. J. N. Andreyev

Summary: Immune checkpoint inhibition is a common treatment for advanced cancers, but its side effects may hinder its effectiveness. Current management recommendations mainly focus on oncology rather than gastroenterology. This report highlights a case of pancreatic insufficiency in a patient receiving PD-1 inhibitor therapy. This problem affects approximately 1 in 100 patients but often goes unrecognized. Gastroenterologists should be aware of the range of gastrointestinal disorders that may occur after immunotherapy for cancer.

FRONTLINE GASTROENTEROLOGY (2023)

添加到收藏夹

Article Oncology

Randomised single centre double-blind placebo controlled phase II trial of Tocovid SupraBio in combination with pentoxifylline in patients suffering long-term gastrointestinal adverse effects of radiotherapy for pelvic cancer: The PPALM study

H. Jervoise N. Andreyev, Jennifer Matthews, Carolyn Adams, Lone Gothard, Claire Lucy, Holly Tovey, Sue Boyle, Selvakumar Anbalagan, Annette Musallam, John Yarnold, David Abraham, Judith Bliss, Bahja Ahmed Abdi, Alexandra Taylor, Martin Hauer-Jensen

Summary: This study aimed to test the efficacy of Tocovid SupraBio and pentoxifylline in improving gastrointestinal symptoms after radiotherapy. However, no clinical benefit was demonstrated. Biochemical data suggest that this intervention has anti-inflammatory and anti-fibrotic effects.

RADIOTHERAPY AND ONCOLOGY (2022)

添加到收藏夹

Article Oncology

Patient perspectives on key symptoms and preferences for follow-up after upper gastro-intestinal cancer surgery

Philip H. Pucher, Annie Coombes, Orla Evans, Joanna Taylor, Jonathan L. Moore, Annabelle White, Jesper Lagergren, Cara Baker, Mark Kelly, James A. Gossage, Jason Dunn, Sebastian Zeki, Ben E. Byrne, Jervoise Andreyev, Andrew R. Davies

Summary: This study surveyed patients who underwent oesophago-gastric surgery to understand their preferences and satisfaction regarding post-operative follow-up. The results showed that longer follow-up and involvement of dietitians improved patient satisfaction.

SUPPORTIVE CARE IN CANCER (2022)

添加到收藏夹

Review Multidisciplinary Sciences

A systematic review and meta-analysis on the prevalence of non-malignant, organic gastrointestinal disorders misdiagnosed as irritable bowel syndrome

Dennis Poon, Graham R. Law, Giles Major, H. Jervoise N. Andreyev

Summary: Treatable gastrointestinal disorders may be overlooked in patients with symptoms typical for irritable bowel syndrome (IBS). Prevalence rates of various gastrointestinal conditions were assessed in consecutive patients meeting diagnostic criteria for IBS, including bile acid diarrhea, carbohydrate malabsorption, microscopic colitis, pancreatic exocrine insufficiency, and small intestinal bacterial overgrowth. The rates of these conditions were significantly higher than in healthy controls, suggesting that a significant proportion of patients with IBS may have an underlying organic condition explaining their symptoms.

SCIENTIFIC REPORTS (2022)

添加到收藏夹

Article Medicine, General & Internal

Sacral osteomyelitis as a rare cause of anorectal pain several years following treatment for rectal carcinoma

Darren C. R. Fernandes, Sangeetha Srinivasan, Hubert Jervoise N. Andreyev

Summary: Our case highlights the importance of appropriate radiological imaging and alerts clinicians to consider osteomyelitis as a differential diagnosis in patients presenting with severe anorectal pain after treatment for rectal cancer.

OXFORD MEDICAL CASE REPORTS (2022)

添加到收藏夹

Review Microbiology

The Role of the Human Gut Microbiome in Inflammatory Bowel Disease and Radiation Enteropathy

Darren Fernandes, Jervoise Andreyev

Summary: The human gut microbiome plays a crucial role in regulating host physiology, with the microbiota and the gut working together in a stable state. Various factors, including disease states and treatments, can affect the overall stability of the intestinal flora. This review compares the well-characterized abnormalities in the microbiome in idiopathic inflammatory bowel disease and radiation enteropathy, and discusses how these changes may function at a molecular level and the potential role of manipulating the microbiome to reduce the severity of the underlying condition.

MICROORGANISMS (2022)

添加到收藏夹

Letter Oncology

Comment on Exploiting dietary fibre and the gut microbiota in pelvic radiotherapy patients

Miguel R. Ferreira, Jervoise N. Andreyev, Linda Wedlake, David P. Dearnaley

BRITISH JOURNAL OF CANCER (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

What is the significance of a faecal elastase-1 level between 200 and 500μg/g?

Alok Mathew, Darren Fernandes, H. Jervoise N. Andreyev

Summary: This retrospective study reports that pancreatic enzyme replacement therapy (PERT) may lead to improvement in gastrointestinal symptoms in patients with faecal elastase-1 (FE-1) levels between 200 and 500 mu g/g. A clinical response was seen in 71% of the patients, particularly in those with potentially predisposing conditions and functional diarrhoea.

FRONTLINE GASTROENTEROLOGY (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Diagnosis and management of bile acid diarrhoea: a survey of UK expert opinion and practice

Julian R. F. Walters, Ramesh Arasaradnam, H. Jervoise N. Andreyev

FRONTLINE GASTROENTEROLOGY (2020)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.